Daiwabo Holdings Co Ltd
TSE:3107
Daiwabo Holdings Co Ltd
TSE:3107
Price:
3 089
JPY
0.59%
Market Closed
Market Cap:
297.7B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Daiwabo Holdings Co Ltd
3089
+18 (+0.59%)
| 52 Week Range |
2 186
3 239
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Daiwabo Holdings Co Ltd
Balance Sheet
Balance Sheet Decomposition
Daiwabo Holdings Co Ltd
Daiwabo Holdings Co Ltd
| Current Assets | 368.1B |
| Cash & Short-Term Investments | 63.2B |
| Receivables | 246.3B |
| Other Current Assets | 58.7B |
| Non-Current Assets | 28.7B |
| PP&E | 10.8B |
| Intangibles | 3.8B |
| Other Non-Current Assets | 14.2B |
| Current Liabilities | 232.8B |
| Accounts Payable | 200B |
| Accrued Liabilities | 2.4B |
| Other Current Liabilities | 30.4B |
| Non-Current Liabilities | 23.6B |
| Long-Term Debt | 13.3B |
| Other Non-Current Liabilities | 10.3B |
Balance Sheet
Daiwabo Holdings Co Ltd
Daiwabo Holdings Co Ltd
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
14 478
|
16 282
|
14 450
|
20 939
|
24 246
|
31 600
|
32 058
|
46 963
|
52 123
|
69 372
|
|
| Cash Equivalents |
14 478
|
16 282
|
14 450
|
20 939
|
24 246
|
31 600
|
32 058
|
46 963
|
52 123
|
69 372
|
|
| Total Receivables |
110 880
|
126 867
|
145 247
|
169 534
|
208 764
|
196 239
|
246 753
|
202 111
|
239 692
|
257 009
|
|
| Accounts Receivables |
110 880
|
126 867
|
145 247
|
169 534
|
208 764
|
196 239
|
246 753
|
179 084
|
235 974
|
253 758
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23 027
|
3 718
|
3 251
|
|
| Inventory |
34 555
|
31 868
|
31 423
|
31 874
|
37 147
|
38 540
|
37 995
|
43 590
|
45 047
|
36 450
|
|
| Other Current Assets |
10 184
|
9 434
|
9 984
|
7 710
|
10 190
|
9 906
|
14 655
|
11 470
|
17 326
|
14 414
|
|
| Total Current Assets |
170 097
|
184 451
|
201 104
|
230 057
|
280 347
|
276 285
|
331 461
|
304 134
|
354 188
|
377 245
|
|
| PP&E Net |
44 990
|
44 367
|
43 676
|
41 987
|
42 167
|
39 522
|
39 172
|
38 272
|
37 127
|
10 238
|
|
| PP&E Gross |
44 990
|
44 367
|
43 676
|
41 987
|
42 167
|
39 522
|
39 172
|
38 272
|
37 127
|
10 238
|
|
| Accumulated Depreciation |
54 439
|
55 395
|
56 189
|
56 482
|
56 891
|
55 049
|
54 996
|
57 263
|
57 553
|
13 175
|
|
| Intangible Assets |
3 172
|
2 492
|
1 845
|
935
|
1 655
|
3 016
|
2 690
|
2 462
|
2 081
|
2 340
|
|
| Goodwill |
6 005
|
4 572
|
3 139
|
1 707
|
767
|
387
|
6
|
0
|
0
|
1 351
|
|
| Note Receivable |
159
|
0
|
176
|
159
|
131
|
140
|
129
|
126
|
57
|
52
|
|
| Long-Term Investments |
7 938
|
6 827
|
6 540
|
6 953
|
6 356
|
5 553
|
6 606
|
6 314
|
6 488
|
9 289
|
|
| Other Long-Term Assets |
2 998
|
2 845
|
3 051
|
4 231
|
4 465
|
3 910
|
3 693
|
4 895
|
6 747
|
4 741
|
|
| Other Assets |
6 005
|
4 572
|
3 139
|
1 707
|
767
|
387
|
6
|
0
|
0
|
1 351
|
|
| Total Assets |
235 359
N/A
|
245 747
+4%
|
259 531
+6%
|
286 029
+10%
|
335 888
+17%
|
328 813
-2%
|
383 757
+17%
|
356 203
-7%
|
406 688
+14%
|
405 256
0%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
105 815
|
115 989
|
125 378
|
146 848
|
179 200
|
158 067
|
188 483
|
161 859
|
192 594
|
206 212
|
|
| Accrued Liabilities |
2 382
|
2 493
|
2 785
|
2 785
|
3 092
|
3 424
|
3 494
|
2 661
|
3 125
|
2 425
|
|
| Short-Term Debt |
10 221
|
10 104
|
10 622
|
11 322
|
11 661
|
8 644
|
6 108
|
7 064
|
6 397
|
4 970
|
|
| Current Portion of Long-Term Debt |
9 449
|
11 883
|
9 632
|
8 975
|
4 428
|
4 116
|
9 369
|
5 707
|
6 665
|
3 599
|
|
| Other Current Liabilities |
10 613
|
11 995
|
14 816
|
13 942
|
19 339
|
18 263
|
23 065
|
14 273
|
23 103
|
22 536
|
|
| Total Current Liabilities |
138 480
|
152 464
|
163 233
|
183 872
|
217 720
|
192 514
|
230 519
|
191 564
|
231 884
|
239 742
|
|
| Long-Term Debt |
28 057
|
21 547
|
19 197
|
17 186
|
19 177
|
19 714
|
13 303
|
15 962
|
14 161
|
13 303
|
|
| Deferred Income Tax |
3 502
|
2 702
|
1 164
|
744
|
745
|
712
|
120
|
2 691
|
2 665
|
1 604
|
|
| Minority Interest |
543
|
580
|
665
|
759
|
801
|
892
|
1 035
|
917
|
966
|
199
|
|
| Other Liabilities |
10 486
|
12 003
|
12 034
|
11 079
|
11 055
|
11 132
|
10 493
|
9 813
|
14 017
|
8 474
|
|
| Total Liabilities |
181 068
N/A
|
189 296
+5%
|
196 293
+4%
|
213 640
+9%
|
249 498
+17%
|
224 964
-10%
|
255 470
+14%
|
220 947
-14%
|
263 693
+19%
|
263 322
0%
|
|
| Equity | |||||||||||
| Common Stock |
21 696
|
21 696
|
21 696
|
21 696
|
21 696
|
21 696
|
21 696
|
21 696
|
21 696
|
21 696
|
|
| Retained Earnings |
24 896
|
29 007
|
35 129
|
43 737
|
57 844
|
75 177
|
97 816
|
106 053
|
119 449
|
115 226
|
|
| Additional Paid In Capital |
7 887
|
7 887
|
7 869
|
7 863
|
7 863
|
7 863
|
7 863
|
7 937
|
7 951
|
7 954
|
|
| Unrealized Security Profit/Loss |
1 786
|
0
|
1 372
|
1 634
|
1 515
|
971
|
1 837
|
1 499
|
1 559
|
3 038
|
|
| Treasury Stock |
552
|
0
|
279
|
111
|
114
|
116
|
123
|
2 123
|
5 137
|
5 133
|
|
| Other Equity |
1 422
|
1 954
|
2 549
|
2 430
|
2 414
|
1 742
|
802
|
194
|
2 523
|
847
|
|
| Total Equity |
54 291
N/A
|
56 451
+4%
|
63 238
+12%
|
72 389
+14%
|
86 390
+19%
|
103 849
+20%
|
128 287
+24%
|
135 256
+5%
|
142 995
+6%
|
141 934
-1%
|
|
| Total Liabilities & Equity |
235 359
N/A
|
245 747
+4%
|
259 531
+6%
|
286 029
+10%
|
335 888
+17%
|
328 813
-2%
|
383 757
+17%
|
356 203
-7%
|
406 688
+14%
|
405 256
0%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
19
|
95
|
96
|
96
|
96
|
96
|
96
|
95
|
93
|
93
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
